Table 3 Spearman correlations for TRF2, Bcl-xL, and p53, together distant metastasis (DM), local recurrence (LR), stage and apoptosis and differentiation (Diff)
From: Expression of TRF2 and its prognostic relevance in advanced stage cervical cancer patients
TRF2 | Bcl-xL | Apoptosis | p53 | DM | LR | Stage | Diff | |
|---|---|---|---|---|---|---|---|---|
TRF2 | 1,000 | -0,032 | 0,453 | -0,179 | -0.471 | -0,300 | 0,216 | -0,171 |
P-value | - | 0,895 | 0,045* | 0,450 | 0.036* | 0,195 | 0,359 | 0,471 |
Bcl-xL | -0,032 | 1,000 | 0,414 | 0,212 | 0.328 | 0,522 | -0,474 | 0,082 |
P-value | 0,895 | - | 0,069 | 0,369 | 0.158 | 0,018* | 0,035* | 0,731 |
Apoptosis | 0,453 | 0,414 | 1,000 | 0,192 | 0.082 | 0,189 | -0,267 | -0,082 |
P-value | 0,045* | 0,069 | - | 0,418 | 0.731 | 0,424 | 0,256 | 0,731 |
p53 | -0,082 | 0,212 | 0,192 | 1,000 | 0.082 | 0,436 | -0,267 | -0,082 |
P-value | 0,731 | 0,369 | 0,418 | - | 0.731 | 0,055 | 0,256 | 0,731 |
DM | -0.474 | 0.328 | 0.082 | 0.082 | 1.000 | 0,471 | -0,391 | 0,667 |
P-value | 0.036* | 0.158 | 0.731 | 0.731 | - | 0,036* | 0,088 | 0,001* |
LR | -0,303 | 0,522 | 0,189 | 0,436 | 0,471 | 1,000 | -0,371 | 0,235 |
P-value | 0,195 | 0,018* | 0,424 | 0,055 | 0,036* | - | 0,107 | 0,317 |
Stage | 0,216 | -0,474 | -0,267 | -0,267 | -0,391 | -0,371 | 1,000 | -0,361 |
P-value | 0,359 | 0,035* | 0,256 | 0,256 | 0,088 | 0,107 | - | 0,118 |
Diff | -0,171 | 0,082 | -0,082 | -0,082 | 0,667 | 0,235 | -0,361 | 1,000 |
P-value | 0,471 | 0,731 | 0,731 | 0,731 | 0,001* | 0,317 | 0,118 | - |